Sirolimus: More cause for alarm?

被引：87

作者：

Agarwal, Parul D. ^{[1
]}

Lucey, Michael R. ^{[1
]}

机构：

[1] Univ Wisconsin, Sch Med & Publ Hlth, Div Gastroenterol & Hepatol, Dept Med, Madison, WI 53792 USA

来源：

LIVER TRANSPLANTATION | 2012年 / 18卷 / 09期

关键词：

HEPATITIS-C VIRUS; LIVER-TRANSPLANTATION; IN-VIVO; FIBROSIS; IMMUNOSUPPRESSION; PROGRESSION; SURVIVAL;

D O I：

10.1002/lt.23473

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：1003 / 1004

页数：2

相关论文

共 10 条

[1]

HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].

Berenguer, M ;

Ferrell, L ;

Watson, J ;

Prieto, M ;

Kim, M ;

Rayón, M ;

Córdoba, J ;

Herola, A ;

Ascher, N ;

Mir, J ;

Berenguer, J ;

Wright, TL .

JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684

[2]

The association between hepatitis C infection and survival after orthotopic liver transplantation [J].

Forman, LM ;

Lewis, JD ;

Berlin, JA ;

Feldman, HI ;

Lucey, MR .

GASTROENTEROLOGY, 2002, 122 (04) :889-896

[3]

Evaluation of a cyclophilin inhibitor in hepatitis C virus-infected chimeric mice in vivo [J].

Inoue, Kazuaki ;

Umehara, Takuya ;

Ruegg, Urs T. ;

Yasui, Fumihiko ;

Watanabe, Tsunamasa ;

Yasuda, Hiroshi ;

Dumont, Jean-Maurice ;

Scalfaro, Pietro ;

Yoshiba, Makoto ;

Kohara, Michinori .

HEPATOLOGY, 2007, 45 (04) :921-928

[4]

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: A meta-analysis [J].

Liang, Wenhua ;

Wang, Dongping ;

Ling, Xiaoting ;

Kao, Andrew Allen ;

Kong, Yuan ;

Shang, Yushu ;

Guo, Zhiyong ;

He, Xiaoshun .

LIVER TRANSPLANTATION, 2012, 18 (01) :62-69

[5]

Limiting Hepatitis C Virus Progression in Liver Transplant Recipients Using Sirolimus-Based Immunosuppression [J].

McKenna, G. J. ;

Trotter, J. F. ;

Klintmalm, E. ;

Onaca, N. ;

Ruiz, R. ;

Jennings, L. W. ;

Neri, M. ;

O'Leary, J. G. ;

Davis, G. L. ;

Levy, M. F. ;

Goldstein, R. M. ;

Klintmalm, G. B. .

AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (11) :2379-2387

[6]

Prediction of liver allograft fibrosis after transplantation for hepatitis c virus: Persistent elevation of serum transaminase levels versus necroinflammatory activity [J].

Pelletier, SJ ;

Iezzoni, JC ;

Crabtree, TD ;

Hahn, YS ;

Sawyer, RG ;

Pruett, TL .

LIVER TRANSPLANTATION, 2000, 6 (01) :44-53

[7]

Hepatitis C virus treatment and liver transplantation in the era of new antiviral therapies [J].

Saxena, Varun ;

Terrault, Norah .

CURRENT OPINION IN ORGAN TRANSPLANTATION, 2012, 17 (03) :216-224

[8]

Trends in post-liver transplant survival in patients with hepatitis C between 1991 and 2001 in the United States [J].

Thuluvath, Paul J. ;

Krok, Karen L. ;

Segev, Dorry L. ;

Yoo, Hwan Y. .

LIVER TRANSPLANTATION, 2007, 13 (05) :719-724

[9]

Impact of sirolimus and tacrolimus on mortality and graft loss in liver transplant recipients with or without hepatitis C virus: An analysis of the Scientific Registry of Transplant Recipients Database [J].

Watt, Kymberly D. ;

Dierkhising, Ross ;

Heimbach, Julie K. ;

Charlton, Michael R. .

LIVER TRANSPLANTATION, 2012, 18 (09) :1029-1036

[10]

Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis [J].

Zhu, JL ;

Wu, J ;

Frizell, E ;

Liu, SL ;

Bashey, R ;

Rubin, R ;

Norton, P ;

Zern, MA .

GASTROENTEROLOGY, 1999, 117 (05) :1198-1204